The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life
- PMID: 20018326
- PMCID: PMC3311463
- DOI: 10.1016/j.juro.2009.09.083
The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life
Abstract
Purpose: We compared urinary incontinence severity measures and the impact of stress urinary incontinence in normal, overweight and obese women.
Materials and methods: Baseline characteristics of subjects in the SISTEr (655) and the TOMUS (597) were analyzed. Body mass index was defined as normal (less than 25 kg/m(2)), overweight (25 to less than 30 kg/m(2)) and obese (30 kg/m(2) or greater). Independent urinary incontinence severity measures included a 3-day diary including incontinence episode frequency, Urogenital Distress Inventory scores and Valsalva leak point pressure from urodynamic testing. Impact was measured using the Incontinence Impact Questionnaire. Multivariable regression models were fit for each severity measure (Urogenital Distress Inventory, incontinence episode frequency, Valsalva leak point pressure and Incontinence Impact Questionnaire) on weight category. Covariates included age, race, diabetes and variables significantly associated with body mass index on bivariate analysis.
Results: Mean age (SD) of participants was 51.9 (10.3) in SISTEr and 52.9 (11.0) in TOMUS. In each trial 45% of subjects were obese. In SISTEr multivariable regression analyses showed that higher weight category was independently associated with higher mean Urogenital Distress Inventory score (p = 0.003), incontinence episode frequency (p <0.0001), Valsalva leak point pressure (p = 0.003) and Incontinence Impact Questionnaire score (p = 0.0004). In TOMUS higher weight category was not associated with Urogenital Distress Inventory score (p = 0.24) but was associated with higher incontinence episode frequency (p = 0.0003), Valsalva leak point pressure (p = 0.0006) and Incontinence Impact Questionnaire score (p <0.0001).
Conclusions: Obese women undergoing surgery for stress urinary incontinence report more incontinence episodes, more symptom distress and worse quality of life despite better measure of urethral function (higher Valsalva leak point pressure) on urodynamics.
Copyright 2010 American Urological Association. Published by Elsevier Inc. All rights reserved.
Comment in
-
Body mass index as a predictor of urological disease and outcomes-overly simplistic?J Urol. 2010 Feb;183(2):427-9. doi: 10.1016/j.juro.2009.11.071. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006860 No abstract available.
References
-
- Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc. 1991;39:378. - PubMed
-
- Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000;48:721. - PubMed
-
- Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001;98:398. - PubMed
-
- Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States 1999–2004. JAMA. 2006;295:1549. - PubMed
-
- Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD, et al. Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women's health across the nation. Am J Epidemiol. 2007;165:309. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK60393/DK/NIDDK NIH HHS/United States
- U01 DK058234/DK/NIDDK NIH HHS/United States
- U01 DK58234/DK/NIDDK NIH HHS/United States
- U01 DK060393/DK/NIDDK NIH HHS/United States
- U01 DK60379/DK/NIDDK NIH HHS/United States
- U01 DK060380/DK/NIDDK NIH HHS/United States
- U01 DK060397/DK/NIDDK NIH HHS/United States
- U01 DK60380/DK/NIDDK NIH HHS/United States
- U01 DK60395/DK/NIDDK NIH HHS/United States
- U01 DK060401/DK/NIDDK NIH HHS/United States
- U01 DK060395/DK/NIDDK NIH HHS/United States
- U01 DK58229/DK/NIDDK NIH HHS/United States
- U01 DK60397/DK/NIDDK NIH HHS/United States
- U01 DK58231/DK/NIDDK NIH HHS/United States
- U01 DK060379/DK/NIDDK NIH HHS/United States
- U01 DK60401/DK/NIDDK NIH HHS/United States
- U01 DK058229/DK/NIDDK NIH HHS/United States
- U01 DK58225/DK/NIDDK NIH HHS/United States
- U01 DK058225/DK/NIDDK NIH HHS/United States
- U01 DK058231/DK/NIDDK NIH HHS/United States
